Member Info for Cranleigh

I don't think that sorting Path (if that deal can be revived), or more broadly selling the remaining O&G assets, will make much difference to the SP or prevent us "moving on".

News of rollouts including AATAC, other rollouts in USA and Europe, seeds, sales figures and consumer offtake data....YES!

In my experience, plenty of bidders build a stake before making a bid, albeit these days the FCA rules mean you have to disclose at 3%.

If they struck now, they would avoid having to pay for an additional up to 110m shares and the cost and a return on Asmilar's associated up to £18.5m future capital input (the warrants not yet exercised).

Our hectic buying of gummies!

Another short squeeze?

News incoming?

The website now shows they are organic and available in only one strength (25mg) - but still out of stock!

Someone’s going to flick that switch soon....

I think the obtention of a Novel Foods Licence is/would be RNS-worthy (an important step for the company and further confirmation that management and their legal advisers are competent and have their ducks in a row).

How terribly sad for any competitors that don't get one.

As I understand it, at present they don't need to have a novel foods licence to sell the gummies.

But to continue selling them after 31 March they need to have filed an application for one....which I am confident they will have done - and probably well before that deadline.

Steve Smith could be advertising pneumatic drills and concrete breakers on the cricket games. #whensandpaperwontdo.

Excellent move.
I guess the strong performance of the cannabis sector in the US since the elections has added to the incentive to do this, and the appointment of Paul Ferguson as VP Corporate Finance has added skills and bandwidth to manage this transition. Neither were hinted at in the Investors’ call a couple of months back - rather the opposite!
For a company based in the US and with initial commercial focus there, it makes great sense.
Very happy.

I had similar - so as we are now in January it surely can’t be long!!

Bellers, a little bird tells me that we may not have long to wait for those delightful gummies! Speaking of which, it has just struck Gin O'Clock.

With a side-order of topping-up for me

InterTrader (Gibraltar) reduced by 0.4% or 2.2m shares on 21 Dec

Does your son also do your sums?
If your average cost was “around 20p”, I think you have made more like £6,600 profit.

Ananda re another share, 25 Nov: "I guess markets look ahead"
Ananda re ZOE today: "Last reported numbers show losses, tiny sales and very small cash balance."
Spot the consistency if you can.
Disingenuous at best.

The "unknown" transactions are simply when the transaction price is exactly mid-way between the bid and ask at the time. That's how LSE's classification of buys and sells works - any transaction above the mid-way price is deemed a Buy, and anything below it a Sell.
Nothing to do with the Spreadex increase, which was anyhow over a week ago and reported late.

Me too, Chesh.
Kind of them to decode "RP" for the benefit of the less worthy.
PS With my paper profits here I'm going to need a lot of banks to be safe from exceeding the £85K FSCS (see what I did there?) guarantee level per bank.

The snake has worked even more magic on the SP than usual this morning!
#slowlearner

Yup, someone had the big hoover out on Friday - 400,000 shares for a cool £260K timed after hours and - due to the algorithm, as it is reported only around midday today - wrongly shows as a "sell".
Explains some of this morning's rise - MMs looking for stock after Mr Dyson passed by?

Great post, Quidditch.
Tamper-evident packaging should be on the agenda for starters, IMHO.